Perspective Therapeutics, Inc. (CATX) stock
CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.75−0.03 (-3.85%)
Close on Nov 20, 2026Market cap $86.05MP/E –Yield –
Perspective Therapeutics cash
Cash and short-term investments held at the end of each period.
Perspective Therapeutics's cash was $236.90M at Jun 30, 2026. For fiscal 2025 it was $144.70M, down 36.2% from the year before. Over ten years it grew 23.4% a year on average. The highest annual figure on record is $226.90M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $144.70M | -36.2% |
| FY2024 | Dec 31, 2024 | $226.90M | +306.0% |
| FY2022 | Jun 30, 2022 | $55.89M | -12.4% |
| FY2021 | Jun 30, 2021 | $63.83M | +2568.4% |
| FY2020 | Jun 30, 2020 | $2.39M | -55.1% |
| FY2019 | Jun 30, 2019 | $5.33M | +55.5% |
| FY2018 | Jun 30, 2018 | $3.43M | -62.6% |
| FY2017 | Jun 30, 2017 | $9.15M | -27.2% |
| FY2016 | Jun 30, 2016 | $12.57M | -13.9% |
| FY2015 | Jun 30, 2015 | $14.59M | -17.5% |
| FY2014 | Jun 30, 2014 | $17.68M | +509.8% |
| FY2013 | Jun 30, 2013 | $2.90M | +8.5% |
| FY2012 | Jun 30, 2012 | $2.67M | +26.5% |
| FY2011 | Jun 30, 2011 | $2.11M | +25.8% |
| FY2010 | Jun 30, 2010 | $1.68M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $236.90M | +23.6% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $270.90M | +28.0% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $144.70M | -36.2% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $174.10M | -35.0% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $191.60M | -34.6% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $211.70M | +17.2% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $226.90M | +306.0% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $267.80M | +354.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $292.90M | +385.3% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $180.60M | +192.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $55.89M | -12.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $58.90M | -9.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $60.35M | +529.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $61.69M | +3079.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $63.83M | +2568.4% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $64.84M | +2596.1% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $9.59M | +201.4% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $1.94M | -57.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.39M | -55.1% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $2.41M | -62.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $3.18M | -59.6% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $4.58M | -50.2% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $5.33M | +55.5% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $6.39M | +41.6% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $7.87M | +38.6% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $9.19M | +26.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $3.43M | -62.6% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $4.52M | -56.6% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $5.68M | -52.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $7.26M | -47.1% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $9.15M | -27.2% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $10.41M | -10.3% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $11.95M | -5.2% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $13.71M | +1.7% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $12.57M | -13.9% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $11.60M | +14.2% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $12.60M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $13.48M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $14.59M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $10.16M | – |
See a number that looks wrong?